Morishita Jintan Co., Ltd. (4524.T)

JPY 2094.0

(0.24%)

Revenue Summary of Morishita Jintan Co., Ltd.

  • Morishita Jintan Co., Ltd.'s latest annual revenue in 2023 was 12.4 Billion JPY , up 9.22% from previous year.
  • Morishita Jintan Co., Ltd.'s latest quarterly revenue in 2024 Q1 was 3.41 Billion JPY , up 12.16% from previous quarter.
  • Morishita Jintan Co., Ltd. reported a annual revenue of 11.35 Billion JPY in annual revenue 2022, up 18.78% from previous year.
  • Morishita Jintan Co., Ltd. reported a annual revenue of 9.56 Billion JPY in annual revenue 2021, up 1.44% from previous year.
  • Morishita Jintan Co., Ltd. reported a quarterly revenue of 3.06 Billion JPY for 2023 Q3, down -3.64% from previous quarter.
  • Morishita Jintan Co., Ltd. reported a quarterly revenue of 3.18 Billion JPY for 2023 Q2, up 2.35% from previous quarter.

Annual Revenue Chart of Morishita Jintan Co., Ltd. (2023 - 2019)

Created with Highcharts 11.1.0YearsRevenue20192019.520202020.520212021.520222022.520239000000000 JPY10000000000 JPY11000000000 JPY12000000000 JPY13000000000 JPY

Historical Annual Revenue of Morishita Jintan Co., Ltd. (2023 - 2019)

Year Revenue Revenue Growth
2023 12.4 Billion JPY 9.22%
2022 11.35 Billion JPY 18.78%
2021 9.56 Billion JPY 1.44%
2020 9.42 Billion JPY -3.63%
2019 9.78 Billion JPY 0.0%

Peer Revenue Comparison of Morishita Jintan Co., Ltd.

Name Revenue Revenue Difference
Pharma Foods International Co., Ltd. 62.14 Billion JPY 80.038%
Takeda Pharmaceutical Company Limited 4263.76 Billion JPY 99.709%
Sumitomo Pharma Co., Ltd. 314.55 Billion JPY 96.056%
Shionogi & Co., Ltd. 435.08 Billion JPY 97.149%
Wakamoto Pharmaceutical Co.,Ltd. 7.73 Billion JPY -60.317%
Nippon Shinyaku Co., Ltd. 148.25 Billion JPY 91.632%
Kaken Pharmaceutical Co., Ltd. 72.04 Billion JPY 82.78%
Eisai Co., Ltd. 741.75 Billion JPY 98.327%
Hisamitsu Pharmaceutical Co., Inc. 141.7 Billion JPY 91.245%
Mochida Pharmaceutical Co., Ltd. 102.88 Billion JPY 87.942%
Fuso Pharmaceutical Industries,Ltd. 55.4 Billion JPY 77.609%
Nippon Chemiphar Co., Ltd. 30.74 Billion JPY 59.653%
Tsumura & Co. 150.84 Billion JPY 91.776%
Kissei Pharmaceutical Co., Ltd. 75.57 Billion JPY 83.585%
Torii Pharmaceutical Co., Ltd. 54.63 Billion JPY 77.294%
Towa Pharmaceutical Co., Ltd. 227.93 Billion JPY 94.557%
Fuji Pharma Co., Ltd. 40.88 Billion JPY 69.659%
Zeria Pharmaceutical Co., Ltd. 75.72 Billion JPY 83.617%
KYORIN Holdings, Inc. 119.53 Billion JPY 89.621%
Taiko Pharmaceutical Co.,Ltd. 5.04 Billion JPY -146.151%
Daito Pharmaceutical Co.,Ltd. 46.89 Billion JPY 73.545%
SymBio Pharmaceuticals Limited 5.58 Billion JPY -121.944%
MedRx Co., Ltd 26 Million JPY -47615.385%
Mizuho Medy Co.,Ltd. 10.98 Billion JPY -12.887%
Solasia Pharma K.K. 617 Million JPY -1910.697%
Modalis Therapeutics Corporation - JPY -Infinity%
ASKA Pharmaceutical Holdings Co.,Ltd. 62.84 Billion JPY 80.259%
Sawai Group Holdings Co., Ltd. 176.86 Billion JPY 92.985%
Cyfuse Biomedical K.K. 61.11 Million JPY -20200.432%
Toho Holdings Co., Ltd. 1476.71 Billion JPY 99.16%
Koa Shoji Holdings Co.,Ltd. 22.13 Billion JPY 43.951%